Kenvue Inc. (NYSE:KVUE) Shares Acquired by ING Groep NV

ING Groep NV boosted its holdings in Kenvue Inc. (NYSE:KVUE) by 23.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,576,616 shares of the company’s stock after acquiring an additional 681,954 shares during the period. ING Groep NV owned 0.19% of Kenvue worth $82,727,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Tokio Marine Asset Management Co. Ltd. grew its holdings in Kenvue by 11.8% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 54,550 shares of the company’s stock valued at $1,262,000 after buying an additional 5,741 shares during the last quarter. Metis Global Partners LLC lifted its position in shares of Kenvue by 1.5% in the third quarter. Metis Global Partners LLC now owns 61,107 shares of the company’s stock valued at $1,413,000 after acquiring an additional 895 shares in the last quarter. SAM Advisors LLC boosted its stake in shares of Kenvue by 2.5% during the third quarter. SAM Advisors LLC now owns 52,459 shares of the company’s stock valued at $1,213,000 after acquiring an additional 1,274 shares during the last quarter. Huntington National Bank increased its position in Kenvue by 26.5% during the 3rd quarter. Huntington National Bank now owns 4,161 shares of the company’s stock worth $96,000 after purchasing an additional 871 shares in the last quarter. Finally, KBC Group NV raised its stake in Kenvue by 114.0% in the 3rd quarter. KBC Group NV now owns 966,160 shares of the company’s stock valued at $22,348,000 after purchasing an additional 514,580 shares during the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have issued reports on KVUE. Bank of America raised their price target on shares of Kenvue from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Tuesday, October 22nd. Deutsche Bank Aktiengesellschaft boosted their price target on Kenvue from $23.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. UBS Group raised their price target on Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 7th. JPMorgan Chase & Co. boosted their price objective on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, Royal Bank of Canada downgraded Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price objective for the company. in a report on Tuesday, September 24th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $22.64.

Kenvue Stock Up 1.9 %

NYSE KVUE traded up $0.44 on Thursday, reaching $23.58. The company had a trading volume of 3,450,168 shares, compared to its average volume of 18,014,807. The firm has a market capitalization of $45.21 billion, a PE ratio of 42.62, a P/E/G ratio of 2.15 and a beta of 1.36. The firm has a 50-day moving average of $22.73 and a 200-day moving average of $20.63. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $23.95. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The business had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same period last year, the business earned $0.31 EPS. The business’s revenue was down .4% on a year-over-year basis. On average, equities research analysts anticipate that Kenvue Inc. will post 1.07 EPS for the current fiscal year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th will be given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.48%. The ex-dividend date is Wednesday, November 13th. Kenvue’s payout ratio is 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.